In Situ Synthesis of an Immune-Checkpoint Blocker from Engineered Bacteria Elicits a Potent Antitumor Response.
Wei Y, Zhang Z, Xue T, Lin Z, Chen X, Tian Y, Li Y, Jing Z, Fang W, Fang T, Li B, Chen Q, Lan T, Meng F, Zhang X, Liang X.
Wei Y, et al.
ACS Synth Biol. 2024 May 31. doi: 10.1021/acssynbio.3c00569. Online ahead of print.
ACS Synth Biol. 2024.
PMID: 38819389